Effect of levosimendan, an inodilator, on renal function in different renal injury models in rats

المشروع

تفاصيل المشروع

Description

Levosimendan is a positive inotropic agent with vasodilating properties. It has been shown to protect the kidneys from ischemia/reperfusion injury, in endotoxemia and in salt-induced hypertension in experimental animals. The aim of this study is to examine if levosimendan has a protective effect on kidney function in three models of renal injury: cisplatin induced nephrotoxicity, diabetic nephropathy and NG-nitro-L-arginine methyl ester (L-NAME) induced- hypertensive nephropathy. Renal injury will be induced by a single injection of cisplatin (6 mg/kg), streptozotocin (60 mg/kg) or by oral administration of L-NAME (75 mg/kg/day for 4 weeks). Levosimendan (0.3 and 1 mg/kg/day) will be orally administered. Renal blood flow (RBF), in addition to several biochemical and pathological indices will be measured

Layman's description

Levosimendan is a positive inotropic agent with vasodilating properties. It has been shown to protect the kidneys from ischemia/reperfusion injury, in endotoxemia and in salt-induced hypertension in experimental animals. The aim of this study is to examine if levosimendan has a protective effect on kidney function in three models of renal injury: cisplatin induced nephrotoxicity, diabetic nephropathy and NG-nitro-L-arginine methyl ester (L-NAME) induced- hypertensive nephropathy. Renal injury will be induced by a single injection of cisplatin (6 mg/kg), streptozotocin (60 mg/kg) or by oral administration of L-NAME (75 mg/kg/day for 4 weeks). Levosimendan (0.3 and 1 mg/kg/day) will be orally administered. Renal blood flow (RBF), in addition to several biochemical and pathological indices will be measured
اختصارTTotP
الحالةلم يبدأ

بصمة

استكشف موضوعات البحث التي تناولها هذا المشروع. يتم إنشاء هذه الملصقات بناءً على الجوائز/المنح الأساسية. فهما يشكلان معًا بصمة فريدة.